OA10670A - Polymorphs of the pro drug 6-n-(l-ala-l-ala)-trovafloxacin - Google Patents

Polymorphs of the pro drug 6-n-(l-ala-l-ala)-trovafloxacin Download PDF

Info

Publication number
OA10670A
OA10670A OA9800027A OA9800027A OA10670A OA 10670 A OA10670 A OA 10670A OA 9800027 A OA9800027 A OA 9800027A OA 9800027 A OA9800027 A OA 9800027A OA 10670 A OA10670 A OA 10670A
Authority
OA
OAPI
Prior art keywords
pii
polymorph
prodrug
monohydrate
treating
Prior art date
Application number
OA9800027A
Other languages
English (en)
Inventor
Timothy Norris
James J Macgarry
Douglas J M Allen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA10670A publication Critical patent/OA10670A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA9800027A 1995-08-29 1998-02-27 Polymorphs of the pro drug 6-n-(l-ala-l-ala)-trovafloxacin OA10670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US510995P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
OA10670A true OA10670A (en) 2000-11-06

Family

ID=21714229

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800027A OA10670A (en) 1995-08-29 1998-02-27 Polymorphs of the pro drug 6-n-(l-ala-l-ala)-trovafloxacin

Country Status (35)

Country Link
US (1) US6080756A (tr)
EP (1) EP0847400B1 (tr)
JP (1) JPH11509188A (tr)
KR (1) KR100274736B1 (tr)
CN (1) CN1193977A (tr)
AP (1) AP639A (tr)
AR (1) AR004507A1 (tr)
AT (1) ATE208790T1 (tr)
AU (1) AU696414B2 (tr)
BR (1) BR9610283A (tr)
CA (1) CA2230303C (tr)
CO (1) CO4480740A1 (tr)
CZ (1) CZ291524B6 (tr)
DE (1) DE69617027T2 (tr)
DK (1) DK0847400T3 (tr)
DZ (1) DZ2088A1 (tr)
ES (1) ES2164892T3 (tr)
GT (1) GT199600061A (tr)
HR (1) HRP960396A2 (tr)
HU (1) HUP9900226A3 (tr)
IL (1) IL122652A (tr)
MA (1) MA23965A1 (tr)
NO (1) NO309039B1 (tr)
NZ (1) NZ310542A (tr)
OA (1) OA10670A (tr)
PL (1) PL185709B1 (tr)
PT (1) PT847400E (tr)
RU (1) RU2151152C1 (tr)
SK (1) SK283354B6 (tr)
TN (1) TNSN96110A1 (tr)
TR (1) TR199800340T1 (tr)
UA (1) UA48982C2 (tr)
WO (1) WO1997008191A1 (tr)
YU (1) YU48296A (tr)
ZA (1) ZA967281B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN105510497A (zh) * 2015-11-30 2016-04-20 精晶药业股份有限公司 L-丙氨酰-l-丙氨酸的定量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
WO1997008191A1 (en) 1997-03-06
CA2230303C (en) 2001-07-24
SK283354B6 (sk) 2003-06-03
NZ310542A (en) 1999-09-29
CA2230303A1 (en) 1997-03-06
EP0847400A1 (en) 1998-06-17
ES2164892T3 (es) 2002-03-01
CZ291524B6 (cs) 2003-03-12
MA23965A1 (fr) 1997-04-01
DE69617027T2 (de) 2002-03-21
UA48982C2 (uk) 2002-09-16
BR9610283A (pt) 1999-03-16
CN1193977A (zh) 1998-09-23
KR100274736B1 (ko) 2000-12-15
HUP9900226A2 (hu) 1999-05-28
NO980863D0 (no) 1998-02-27
EP0847400B1 (en) 2001-11-14
PL185709B1 (pl) 2003-07-31
SK23798A3 (en) 1999-05-07
JPH11509188A (ja) 1999-08-17
TR199800340T1 (tr) 1998-06-22
PL325203A1 (en) 1998-07-06
CZ55298A3 (cs) 1999-02-17
AU6135196A (en) 1997-03-19
DZ2088A1 (fr) 2002-07-22
ATE208790T1 (de) 2001-11-15
NO309039B1 (no) 2000-12-04
IL122652A (en) 2000-01-31
HRP960396A2 (en) 1998-04-30
DK0847400T3 (da) 2002-03-25
TNSN96110A1 (fr) 2005-03-15
HUP9900226A3 (en) 1999-11-29
ZA967281B (en) 1998-03-02
AP639A (en) 1998-04-14
US6080756A (en) 2000-06-27
AP9600854A0 (en) 1996-10-31
AR004507A1 (es) 1998-12-16
CO4480740A1 (es) 1997-07-09
KR19990044231A (ko) 1999-06-25
YU48296A (sh) 1998-12-23
PT847400E (pt) 2002-03-28
AU696414B2 (en) 1998-09-10
IL122652A0 (en) 1996-08-16
GT199600061A (es) 1998-01-31
MX9801665A (es) 1998-08-30
NO980863L (no) 1998-02-27
DE69617027D1 (de) 2001-12-20
RU2151152C1 (ru) 2000-06-20

Similar Documents

Publication Publication Date Title
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
UA43841C2 (uk) Імідазопіридини та фармацевтична композиція на їх основі
JP3145715B2 (ja) 無水７−（［１α，５α，６α］−６−アミノ−３−アザビシクロ［３．１．０］ヘキサ−３−イル）−６−フルオロ−１−（２，４−ジフルオロフェニル）−１，４−ジヒドロ−４−オキソ−１，８−ナフチリディン−３−カルボン酸メタンスルホン酸塩の新規な結晶形態
KR20240021239A (ko) Cdk 키나아제 억제제로 사용되는 화합물 및 이의 용도
OA10670A (en) Polymorphs of the pro drug 6-n-(l-ala-l-ala)-trovafloxacin
AU704115B2 (en) Zwitterionic forms of trovafloxacin
US20030069417A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
CZ290550B6 (cs) Krystalický (+) L-hydrogenvinan 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridinu, způsob jeho přípravy, farmaceutický prostředek jej obsahující a jeho pouľití
US5786449A (en) Streptogramin derivatives, their preparation and pharmaceutical compositions which contain them
US6066647A (en) Zwitterionic forms of trovafloxacin
JPS59199693A (ja) インドリルグリシルセフアロスポリン誘導体
KR20030027094A (ko) 신규 에스테르 또는 아미드 유도체
CS236782B2 (en) Processing of 5 s-(2r-butyl)peptidergotalkaloid
MXPA98001665A (en) Polymorphoses of profarmaco of 6-n- (l-ala-l-ala) -trovafloxacin, procedure for its preparation and use of mis
CZ20032722A3 (cs) Merkaptoacetylamidové deriváty, způsob jejich přípravy a farmaceutické prostředky s jejich obsahem k ošetřování kardiovaskulárních onemocnění
MXPA98001664A (en) Zwitterionic forms of trovafloxacin, procedure for its preparation, compositions that contain them and use of the mis
JP2001527076A (ja) 海綿動物から単離されるアスマリンａ及びｂを含む細胞毒性アルカロイド誘導体